Model
Edge
Regeneron Pharmaceuticals, Inc.
0001226690
Filing Type
144
Filing Date
5/14/2024
Updated
5/15/24, 2:16 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities